Christian M. Becker

ORCID: 0000-0002-9870-9581 · 182 papers in corpus
observational 2024
·doi:10.1101/2024.07.08.24310092

Abstract The evidence for a greater prevalence of immunological-diseases among endometriosis patients has varied in robustness and been subject to selection bias. We investigated the phenotypic and genetic association between endometriosis …

rct 2024
Human Reproduction ·doi:10.1093/humrep/dead263

STUDY QUESTION: What is the efficacy and safety of long-term treatment (up to 2 years) with relugolix combination therapy (CT) in women with moderate to severe endometriosis-associated pain? SUMMARY ANSWER: For up to 2 years, treatment wit…

meta-analysis 2023
·doi:10.1142/s2661318223743655

Background and Aims: Numerous endometriosis treatments exist, ranging from surgical to traditional medications to complementary and alternative medicines (CAMs). The ranking of treatments across management categories remains unknown. To add…

2023
·doi:10.1101/2023.11.03.564728

Abstract The human endometrium, the inner lining of the uterus, exhibits complex, dynamic changes throughout the menstrual cycle in response to ovarian hormones. Aberrant response of endometrial cells to hormones is associated with multiple…

other 2023
Pain management ·doi:10.2217/pmt-2023-0052

WHAT IS THIS SUMMARY ABOUT?: This is a summary of research studies (known as clinical trials) called SPIRIT 1 and SPIRIT 2. The SPIRIT 1 and SPIRIT 2 studies compared how well a medicine called relugolix combination therapy worked in reliev…

observational 2023
Frontiers in reproductive health ·doi:10.3389/frph.2023.1140857

INTRODUCTION: Chronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid con…

observational 2023
Pain ·doi:10.1097/j.pain.0000000000002955

Chronic pelvic pain (CPP), despite its high prevalence, is still relatively poorly understood mechanistically. This study, as part of the Translational Research in Pelvic Pain (TRiPP) project, has used a full quantitative sensory testing (Q…

other 2023
Trials ·doi:10.1186/s13063-023-07386-x

BACKGROUND: Endometriosis affects 190 million women and those assigned female at birth worldwide. For some, it is associated with debilitating chronic pelvic pain. Diagnosis of endometriosis is often achieved through diagnostic laparoscopy.…

other 2023
Nature communications ·doi:10.1038/s41467-023-35974-7

Uterine leiomyomata (UL) are the most common tumours of the female genital tract and the primary cause of surgical removal of the uterus. Genetic factors contribute to UL susceptibility. To add understanding to the heritable genetic risk fa…

2023
·doi:10.1016/b978-0-323-91380-5.00018-6
other 2023
Communications biology ·doi:10.1038/s42003-023-05070-z

Endometriosis is a leading cause of pain and infertility affecting millions of women globally. Herein, we characterize variation in DNA methylation (DNAm) and its association with menstrual cycle phase, endometriosis, and genetic variants t…

review 2023
Frontiers in reproductive health ·doi:10.3389/frph.2023.1130849

Endometriosis is an inflammatory disease that is defined as the growth of endometrium-like tissue outside the uterus, commonly on the lining of the pelvic cavity, visceral organs and in the ovaries. It affects around 190 million women of re…

diagnostic-accuracy 2023
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.15062

OBJECTIVE: To evaluate blood-based biomarkers to detect endometriosis and/or adenomyosis across nine European centers (June 2014-April 2018). METHODS: This prospective, non-interventional study assessed the diagnostic accuracy of 54 blood-…

rct 2023
·doi:10.1093/humrep/dead093.027

Abstract Study question Does once-daily linzagolix for up to 6 months reduce the pain symptoms in women with endometriosis? Summary answer Once-daily oral use of the GnRH agonist linzagolix alone or in combination with combined hormonal add…

rct 2023
·doi:10.1093/humrep/dead093.032

Abstract Study question To assess the effect of oral relugolix combination therapy (Relugolix-CT) in the subgroup of women with endometriosis-associated pain who received prior first-line hormonal treatment. Summary answer Relugolix-CT sign…

observational 2023
PloS one ·doi:10.1371/journal.pone.0287469

INTRODUCTION: Caesarean section (C-section) is a life-saving procedure when medically indicated but unmet need and overuse can add to avoidable morbidity and mortality. It is not clear whether C-section has a negative impact on breastfeedin…

observational 2023
European journal of public health ·doi:10.1093/eurpub/ckad216

BACKGROUND: There are limited data on endometriosis from the Eastern Mediterranean region. This study for the first time estimates the prevalence and impact of endometriosis on women in Northern Cyprus, an under-represented region in Europe…

meta-analysis 2023
Nature genetics ·doi:10.1038/s41588-023-01323-z

Endometriosis is a common condition associated with debilitating pelvic pain and infertility. A genome-wide association study meta-analysis, including 60,674 cases and 701,926 controls of European and East Asian descent, identified 42 genom…

meta-analysis 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1225639

BACKGROUND: Endometriosis is a chronic disease affecting 6-10% of women of reproductive age. It is an important cause of infertility and chronic pelvic pain with poorly understood aetiology. CD8+ T (CD8 T) cells were shown to be linked to i…

review 2023
Human Reproduction ·doi:10.1093/humrep/dead216

Endometriosis is defined by the presence of extrauterine endometrial-like tissue, which can cause pain and infertility in 10% of reproductive-age women. To date, the pathogenesis is poorly understood resulting in significant diagnostic dela…

meta-analysis 2023
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd011345.pub3

BACKGROUND: Many factors influence fertility, one being the timing of intercourse. The 'fertile window' describes a stage in the cycle when conception can occur and is approximately five days before to several hours after ovulation. 'Timed …

2022
·doi:10.1016/j.ejogrb.2021.11.131
other 2022
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.17166

Fertility preservation (FP) is an established and recognised intervention for those undergoing gonadotoxic treatments, principally for malignancy. The surgical treatment of endometrioma and the disease itself reduce ovarian reserve and has …

other 2022
Nature communications ·doi:10.1038/s41467-022-33222-y
observational 2022
·doi:10.1101/2022.10.03.22280515

Abstract Chronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid conditio…